In the Journals

Impaired immune response to intestinal fungi may play a role in IBD

January 11, 2018
Researchers found that certain types of immune cells called CX3CR1+ mononuclear phagocytes play a key role in innate and adaptive immune responses to…
In the Journals Plus

Oral bacteria linked to decreased risk for head and neck cancer

January 11, 2018
Greater oral abundance of Corynebacterium and Kingella decreased risk for head and neck squamous cell cancer, according to published findings…
In the Journals

Fecal transplant from overweight donor does not impact BMI in C. difficile patients

January 9, 2018
Patients with Clostridium difficile infection who received a single fecal microbiota transplantation using stool from an overweight or obese donor…

Microbiome data support clinical efficacy of UC drug candidate

January 4, 2018
Seres Therapeutics revealed microbiome data from its phase 1b study of SER-287, which showed bacteria derived from the study drug engrafted into the…

Microbiome news highlights from 2017: emerging treatments, autism, obesity, NIH conference

December 29, 2017
The emerging importance of the role the gut microbiome plays in human health continued to dominate headlines throughout 2017. This year, microbiome…
In the Journals

FDA should view FMT donor stool as tissue, regulate stool banks, experts say

December 20, 2017
In a policy piece published in Science, experts critical of the FDA’s recently proposed regulations for fecal microbiota transplantation…
In the Journals

Fecal transplant shows long-term safety for recurrent C. difficile

December 14, 2017
Fecal microbiota transplantation for recurrent Clostridium difficile infection showed long-term safety and benefits over antibiotic therapy in a…
In the Journals

Microbiome integral to precision diagnosis, personalized treatment

December 6, 2017
Advances in microbiome science will play a key role in a new era of patient care, enabling precision diagnostics and personalized treatment…
FDA News

FDA grants orphan designation to microbiome drug for pediatric UC

December 4, 2017
Seres Therapeutics announced the FDA has given its microbiome drug candidate SER-287 Orphan Drug Designation for the treatment of pediatric…
In the Journals

Poor oral health linked to precancerous stomach lesions

November 28, 2017
Individuals with higher numbers of oral pathogens associated with periodontal disease may be at risk for precancerous gastric lesions, according to…